EGFR and lung cancer: The MAPK signaling activation in the carcinogenesis of invasive bladder transition cell carcinomas has been addressed by a meta-analysis study [36], whereas the PI3K/Akt pathway is implicated as the target of miR-30a to overcome EGFR inhibitor resistance in lung cancer [37].